BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Drug Discovery

FDA Takes Steps to Increase Availability of COVID-19 Vaccine

The agency is announcing today that it is authorizing for use, under the emergency use authorization (EUA) for the Janssen COVID-19 vaccine, two batches of...

June 12, 2021 | News

PerkinElmer to help speed drug discovery

Leading academic, research and industry group led by Broad Institute to help speed drug discovery PerkinElmer, Inc., a global leader committed to ...

June 11, 2021 | News

FDA’s Decision to Approve New Treatment for Alzheimer’s Disease

This approval is significant in many ways. Aduhelm is the first novel therapy approved for Alzheimer’s disease since 2003. Perhaps more significantly...

June 09, 2021 | News | By Dr. Patrizia Cavazzoni, Director, FDA Center for Drug Evaluation and Research

Merck’s KEYTRUDA® Given After Surgery Reduced the Risk of Disease Recurrence or Death

First-Time Disease-Free Survival Data to be Presented During Plenary Session at the 2021 ASCO Annual Meeting Merck’s KEYTRUDA® (pemb...

June 07, 2021 | News

Samsung Pharm & GemVax present pancreatic cancer immunotherapeutic drug, RIAVAX™

ASCO 2021, which celebrates its 57th anniversary this year, runs from June 4th to June 8th and will be held virtually due to COVID-19. Some ...

June 07, 2021 | News

China NMPA Approves MicuRx's Contezolid for Treatment of Drug-Resistant Bacterial Infection

By leveraging the proprietary technology platform built for drug discovery and screening, MicuRx R&D team discovered the next-generation oxazolidinone ...

June 04, 2021 | News

TLC and Strides partner to launch Black Fungus Drug in India

TLC (Nasdaq: TLC, TWO: 4152), a clinical‐stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, and...

June 02, 2021 | News

Mycovia Pharmaceuticals Submits New Drug Application to the U.S. FDA

Also known as chronic yeast infection, RVVC is a debilitating infectious condition defined as three or more episodes per year. Although RVVC affects nearly...

June 02, 2021 | News

Kinarus presents plans for a drug against Long Covid

The drug Kin.001 is at the beginning of the clinical trial phase and will be on the market at the end of 2022, said CEO Alexander Bausch in a video report ...

June 02, 2021 | News

Novartis provides update on BEOVU clinical program

Novartis has also decided on early termination of the RAPTOR and RAVEN studies, which assessed the efficacy and safety of brolucizumab in retinal vein occl...

May 30, 2021 | News

Liminal BioSciences Update Clinical Activities for Fezagepras

Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company, announced today that bas...

May 31, 2021 | News

Merck,has launched a new, high-purity synthetic cholesterol product

To meet the high demand for lipids, a key component of mRNA-based vaccines and therapeutics, Merck, a leading science and technology company, has launched ...

May 26, 2021 | News

Nanoform and Celanese Explore Ways to Enhance Drug Delivery

The goal is to assess the utility of combining Nanoform's nanoparticle platform technologies with Celanese's VitalDose® EVA copolymer delivery tec...

May 26, 2021 | News

Roche’s Antibody Cocktail now available in India

Casirivimab and Imdevimab is indicated for restricted use in emergency situation for the treatment of mild to moderate COVID-19 in patients who are at high...

May 24, 2021 | News

Stay Connected